Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Mpox // Monkeypox
Pneumococcal disease
2022
Europe
Clear all
Type of publications
NITAG documentation
(36)
Systematic reviews (SYSVAC)
(9)
Topics
Available to download in languages
Regions
Europe
(45)
Africa
(24)
Americas
(50)
Eastern Mediterranean
(3)
South-East Asia
(2)
Western Pacific
(20)
Countries
Belgium
(8)
France
(10)
Germany
(2)
Ireland
(6)
Italy
(1)
Luxembourg
(3)
Netherlands
(1)
Spain
(2)
Ukraine
(1)
United Kingdom
(6)
Diseases
COVID-19
(34)
Mpox // Monkeypox
(8)
Pneumococcal disease
(3)
Herpes zoster
(3)
Human papillomavirus (HPV)
(4)
Influenza
(5)
Meningococcal disease
(1)
Pertussis
(1)
Rabies
(1)
Rotavirus
(2)
Vaccine topics
Acceptance
(4)
Administration
(1)
Coverage
(4)
Economic aspects
(1)
Ethical issues
(4)
Target population
Adolescents
(1)
Adults
(1)
All age groups
(6)
Children
(3)
Healthcare workers
(3)
Newborn
(2)
Older adults
(1)
Parents/caregivers
(2)
Pregnant women
(1)
Risk group
(1)
Travellers
(1)
Publication date
2022
(45)
2024
(1)
2023
(20)
2021
(78)
2020
(20)
2019
(4)
2018
(4)
2017
(6)
2016
(4)
2015
(4)
2014
(2)
2013
(3)
2012
(1)
2011
(2)
2010
(5)
2009
(2)
2006
(1)
2005
(3)
45 results found
2022
∙
Conseil Supérieur des Maladies Infectieuses
CSMI recommendation on dosage and route of administration Jynneos/Imvanex monkeypox vaccine.
2022
∙
Conseil Supérieur des Maladies Infectieuses
CSMI Recommendation on Monkeypox – Update July 25, 2022
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against pneumococcal disease for adults in Belgium
2022
∙
Conseil Supérieur de la Santé (CSS)
Belgium Vaccination strategy against Monkeypox (revision, August 2022)
2022
∙
NIAC
NIAC Recommendations for additional COVID-19 Booster Vaccination
2022
∙
NIAC
Recommendations for the use of Monkeypox Modified Vaccinia Ankara Vaccines, Imvanex or Jynneos, by the intradermal route
2022
∙
Conseil Supérieur de la Santé (CSS)
Booster vaccination for children and adolescents
2022
∙
Conseil Supérieur de la Santé (CSS)
Booster vaccination for immunocompromised patients
2022
∙
Conseil Supérieur de la Santé (CSS)
COVID-19 vaccination: Autumn / Winter season 2022 – 2023 in Belgium
2022
∙
Health Council of the Netherlands
Executive summary of the Second booster vaccination against COVID-19
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register